Tags |
|
|
Links |
|
|
Digg It - Preparation of the Marketing Campaign: Pricing
Keyword Concepts: decisions affecting price setting
Pricing
Pricing
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
: the third element of the marketing mix is an important and
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
complex consideration in formulating the marketing strategy.
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
Yet it is the variable that normally produces the most direc
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
and most rapid change in customer value and competitive imp
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
ct.
Price setting consists of more than adding a standard m
Price setting consists of more than adding a standard m
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
rk up to a given cost.
Pricing is one of the marketing mix
Pricing is one of the marketing mix
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
lements that can be varied to achieve the marketing objectiv
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
of the firm. Thus a marketer willing to position a product
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
s a high-quality item will sets up a high price to emphasize
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
quality.
The need for price decisions differs for different
The need for price decisions differs for different
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
types of goods and from market to market. In the case of st
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
ndardized or relatively undifferentiated products, the marke
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
sets the price and the seller has little control over the l
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
vel of prices.
The same happens in situations where the gov
The same happens in situations where the gov
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
rnment price controls prevail or prices are fixed through pa
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
en-licensing agreements. In setting its pricing policies, th
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
company has two basic choices. It may use the prices as an
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
ctive instrument for accomplishing market objectives. Or it
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
ay consider prices as a static element in business decisions
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.diggit.org.ua/article/28591/diggit-Preparation-of-the-Marketing-Campaign-Pricing.html">Preparation of the Marketing Campaign: Pricing</a>
BB link (for phorums):
[url=http://www.diggit.org.ua/article/28591/diggit-Preparation-of-the-Marketing-Campaign-Pricing.html]Preparation of the Marketing Campaign: Pricing[/url]
Related Articles:
Make Money On Wall Street And Main Street
Business Accounting and Your Business Success
Building a Better Client Base: Five Easy Steps
Bookmark it:
|